Article
The ataxia telangiectasia-mutated target site Ser18 is required for p53-mediated tumor suppression.
Cancer research - 15 Dec 2007
Armata Heather L, Garlick David S, Sluss Hayla K
Abstract excerpt
The p53 tumor suppressor is phosphorylated at multiple sites within its NH(2)-terminal region. One of these phosphorylation sites (mouse Ser(18) and human Ser(15)) is a substrate for the ataxia telangiectasia-mutated (ATM) and ATM-related (ATR) protein kinases. Studies of p53(S18A) mice (with a g...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
